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Part 1: Introduction 
1.1 Purpose  
This report provides a progress update on the Government's Tackling Methamphetamine 
Action Plan (The Action Plan). It specifically: 
 records changes against the Action Plan's baseline data, and 
 details progress on the Action Plan's activities. 
 
1.2 Latest data and reports on progress provided six monthly 
When the Action Plan was launched, Chief Executives from DPMC, Health, Customs, 
Justice, Police, Corrections and Te Puni Kokiri were charged with reporting on progress 
every six months from October 2009 to October 2012. DPMC coordinates the reporting 
process and the Methamphetamine Steering Group, made up of senior officials from the 
relevant agencies, meets to approve the reports. This is the sixth and final of the originally 
scheduled progress reports. 
 
1.3 Where to next 
Six-monthly progress reports will continue to be released to provide visibility of the 
methamphetamine problem and actions to address it. In order to make the progress reports 
more user-friendly, future reports will be simplified.  
 
The need for changes to the Action Plan will be considered in the second half of 2013 once 
the National Drugs Policy is finalised. 
 
1.4 Data should be used with caution 
Descriptions of information sources and further details are provided in appendices. It should 
be noted that, due to various recording and release dates, some data is provisional and other 
data may have been collected but not yet analysed. Therefore some changes may be 
evident when all data is confirmed and this will be corrected in subsequent reporting if 
necessary.  
 
1.5 Overview of expected results and indicators 
The summary of expected results, indicators and sources of indicators are shown on the next 
three pages.  
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Part 2: Progress on actions 
 
Action Progress to date Status Plan to remedy  
(if required) 
Intervention group 2.1 Crack down on precursors 
End the availability of over the 
counter pseudoephedrine (PSE) 
from pharmacies. 
 The Act to reclassify pseudoephedrine as a Class 
B2 drug came into effect in September 2011. 
 Many pharmacists voluntarily withdrew PSE 
products from shelves ahead of the legislation.  
 One major branded product is now available by 
prescription only. 
Completed  
Establish a Precursor Working 
Group (PWG) to investigate 
stronger controls on other 
precursor chemicals and other 
products used in the 
manufacture of 
methamphetamine.  
 The PWG involving government and industry 
representatives has been established.  Work is 
currently underway with the Environmental 
Protection Authority (EPA) to develop enhanced 
controls on the supply, storage and use of certain 
precursor chemicals under the Hazardous 
Substances and New Organisms Act 1996. 
Ongoing  
Investigate a comprehensive 
programme of detailed chemical 
and purity analysis of drug 
seizures. 
 Environmental Science and Research (ESR) 
provided the final report from its Drug Signature 
pilot programme to National Drug Intelligence 
Bureau (NDIB), Customs and Police.  Purity 
remains high at a gram level. 
 To further test purity another 50 sample 
programme is underway, which involves more 
detailed testing methodologies than were used in 
the original pilot. The samples are based on 
Customs and Police seizures from the past 12 
months. It is hoped this will provide further strategic 
and tactical intelligence about the 
methamphetamine scene.  The testing will include 
smaller samples, to assist us in determining 
whether street quantities of methamphetamine 
(points) have been ‘cut’ prior to sale. 
 
Ongoing  
Intervention group 2.2 Break supply chains 
Develop and action a Police 
Methamphetamine Control 
Strategy (MCS). 
 The Police MCS was launched in 2009. It is a 
restricted document that contains concrete, 
evidence-based and measurable actions that 
Police Groups and Districts must undertake and 
report against. The MCS is reviewed annually to 
ensure that it anticipates and responds to emerging 
trends. 
 The 2012/13 MCS was launched on 1 July 2012.  It 
focuses on the following four themes: enhancing 
national intelligence to better inform priorities and 
targets; targeting highest risk methamphetamine 
manufacturers and suppliers; using tailored 
interventions to prevent and combat 
methamphetamine manufacture and supply; and 
supporting communities to reduce and prevent 
methamphetamine use.   
Ongoing  
Introduce measures to increase 
interception rates of 
methamphetamine and 
precursors at the border through 
 Blitz operations occur regularly.   Ongoing  
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Action Progress to date Status Plan to remedy  
(if required) 
better risk profiling and targeting.  
Expand Customs investigations 
team and technical surveillance 
capacity to enable more effective 
follow up to precursor 
interceptions at the border. 
 Additional staff have been assigned to Customs 
Investigation Units.   
 The enhanced tracking and surveillance equipment 
capability project is nearing completion. Training on 
use of the new capabilities will be completed by the 
end of 2012 and operating guidelines have been 
developed and verified against international 
guidelines.  Initial trial deployments of the tracking 
and surveillance equipment in live cases have met 
expectations. 
 This technology will become an important element 
of future drug enforcement work and will improve 
the ability of agencies to successfully target higher-
end drug importing syndicates. 
Ongoing  
Ensure agencies are ready to 
use new legislative tools such as 
anti-money laundering, 
organised crime, and search and 
surveillance. 
 Since the Criminal Proceeds (Recovery) Act came 
into effect in December 2009 New Zealand Police 
have investigated an estimated $208 million worth 
of assets suspected to have been obtained through 
or derived from criminal activity. 
 Of the estimated $208 million investigated, an 
estimated $136 million is attributed to drug 
offending, of which, $57.4 million relates 
specifically to methamphetamine offending. 
Ongoing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The NZ Financial Intelligence Unit (FIU) continues 
to fully engage with partner agencies on the work 
streams identified in 'Strengthening New Zealand's 
Resistance to Organised Crime'.  As part of this 
initiative, the first phase of the Anti-Money 
Laundering and Countering Financing of Terrorism 
(AML/CFT) Act 2009 comes into full effect in June 
2013. To meet responsibilities under the AML/CFT 
Act the FIU will have a new suspicious transaction 
reporting system in place prior to this deadline (the 
United Nations produced 'goAML'). 
 The second phase of this legislation will widen the 
number of reporting entities that will be covered by 
the AML/CFT Act. At this stage there is no firm 
timeframe for when this work will commence. 
 All parts of the Search and Surveillance Act 2012 
have now been enacted. Provisions relating to 
surveillance devices came into force on 18 April 
2012, and the remaining provisions, including those 
relating to Police and other enforcement officers’ 
powers, came into force on 1 October 2012.  
 Police and other enforcement agencies have 
completed training on the Act's provisions. 
Allocate, via the normal Budget 
process monies forfeited under 
the Criminal Proceeds 
(Recovery) Act 2009 to fund 
expansion of alcohol and other 
drug treatment, including 
methamphetamine and 
continuing care services and 
Police/ Customs initiatives to 
 Net funds are being held by the Official Assignee. 
No monies have been allocated to agencies to fund 
anti-drug activities as yet.  
On-going, 
but 
transfer of 
monies is 
behind 
schedule  
Officials are working 
through options to 
address this action 
next year.   
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Action Progress to date Status Plan to remedy  
(if required) 
fight organised criminal groups 
dealing in methamphetamine and 
other drugs. 
Improve coordination to ensure 
that Immigration is alerted when 
individuals in breach of permit 
conditions appear to be involved 
in drug operations.  
 
 
 Immigration staff are routinely attached to work with 
Customs and Police as part of intensive targeting 
operations. 
Ongoing  
Intervention group 2.3 Provide better routes into treatment 
Increase the capacity of alcohol 
and drug treatment services to 
provide more spaces for 
methamphetamine users. 
 Since November 2009, 60 residential treatment 
beds for methamphetamine users, in addition to 
those funded through District Health Boards 
(DHBs), have been contracted by the Ministry of 
Health (MOH). All 60 residential beds are now 
operational. Since 2009 there have been over 540 
new admissions into residential treatment, as at 30 
September 2012. 
 Since November 2009, 20 social detox beds for 
methamphetamine users, in addition to those 
funded through DHBs, have been contracted by 
MOH.  As of 30 September 2012, over 500 people 
have been through social detoxification. 
 Contracts for services were renewed from 1 July 
2012. There has been some re-distribution of 
contracts based on observed use/need, with 
additional capacity provided in Northland, Bay of 
Plenty, and Otago. 
Complete  
Increase alcohol and drug 
workforce capacity and capability 
to respond effectively to 
methamphetamine. 
 Focus has been on: 
- expanding alcohol and other drugs (AOD) 
treatment services with the capacity and capability 
to treat methamphetamine users, through training 
(including formal education), guidelines and 
recruitment initiatives 
- increasing the numbers of frontline people with 
the ability to screen and provide brief interventions 
for polydrug (including methamphetamine) users. 
Ongoing 
 
 
 
Improve routes into treatment 
through increased referral of 
methamphetamine users at an 
early stage of contact with the 
justice system.  
 The number and proportion of offenders with 
methamphetamine convictions receiving AOD 
assessments as a condition of sentence has 
increased steadily in recent years, 213 (16.8% of 
total) in 2008 rising to 267 (21.3% of total) in 2011. 
 In October 2011, Cabinet approved an additional 
$10 million per year for AOD assessments and 
treatment interventions (including 
methamphetamine) under the Drivers of Crime 
work. Key initiatives include additional low cost, 
high volume community-based treatment for 
offenders with AOD problems; AOD treatment and 
support as part of a pilot AOD Court in the 
Auckland metro area; and additional funding for 
training and workforce development. The $10 
million investment package will be implemented 
over the 2012/13 year.  
 The design of the pilot AOD Court is currently 
Ongoing  
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Action Progress to date Status Plan to remedy  
(if required) 
underway in consultation with key stakeholders and 
judiciary. It is expected to operate from November 
2012 and will run for five years. Methamphetamine 
users will be eligible for participation in the 
programme. 
Improve routes into treatment 
through contact with frontline 
government funded services.  
 
 
 
  An earlier action, involving Department of 
Corrections, Ministry of Health and Matua Raki, 
developing a training programme for Probation 
Officers, prison Case Managers, and primary 
healthcare nurses working in prisons, has been 
integrated into a wider Corrections-led AoD 
Strategy.  A training programme for prison nurses 
and case managers has been developed.  
Following delivery of the training, AoD screening 
and brief interventions will commence at two pilot 
prison sites in November 2012. 
Ongoing  
Bring forward the review of the 
Alcoholism and Drug Addiction 
Act 1966 to develop a more 
effective mechanism to mandate 
treatment. 
 Cabinet approved policy proposals for new 
legislation in November 2010 which, once enacted, 
will enable Court-ordered compulsory treatment for 
serious substance users. 
 A draft Bill has been prepared by Parliamentary 
Counsel Office and is awaiting introduction to the 
House.  In the meantime, officials continue to work 
with the sector on how implementation will work. 
Behind 
schedule 
The Bill is priority 4 – 
to be referred to 
Select Committee in 
this Parliamentary 
year. 
Intervention group 2.4 Support communities 
Strengthen best practice 
community programmes, such as 
Community Action Youth and 
Drugs (CAYADs). 
 
 
 
 
 
 CAYAD sites around the country continue to initiate 
and deliver community approaches on alcohol and 
drug issues including methamphetamine.   
 A review of the CAYAD programme was completed 
in October 2011.  The review was broadly 
supportive of the work of local CAYAD sites to 
address the impact of alcohol and drugs in 
communities, including methamphetamine where 
this is a drug of concern.  Funding for current 
CAYAD sites has been confirmed until 2015. 
 In September 2011, the Auckland Council released 
its Auckland Regional Methamphetamine Action 
Plan.  The Plan was established by the Auckland 
Regional Methamphetamine Working Group 
(ARMWG).  The three Auckland CAYAD sites play 
an integral role in leading and coordinating 
ARMWG and actions under the Plan. 
 On 25 May 2012 ARMWG held a 
Methamphetamine Awareness Seminar at the 
University of Auckland.  ARMWG is also 
developing a communications plan with key 
prevention and harm reduction messaging and has 
initiated training days to provide information on 
each of the work streams under the Plan. 
Ongoing  
Educate families/whānau and 
users about effects of 
methamphetamine and how to 
access treatment through a 
centralised web resource. 
 MethHelp and DrugHelp websites continue to be 
well accessed. There have been over 25,000 visits 
to the MethHelp site and 10,000 MethHelp booklets 
have been ordered since they became available in 
August 2010. 
Ongoing  
Promote the new Drug Education 
Guidelines. 
 The Guide to Drug Education in Schools has been 
published on the Ministry of Education website, 
Ongoing 
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Action Progress to date Status Plan to remedy  
(if required) 
with links to the Guide posted onto relevant 
curriculum and leadership sites. Between April 
2012 and September 2012 the webpage was 
viewed 141 times and the Drug Education 
Guidelines downloaded 54 times. 
Increase the reach of school 
programmes targeted to at-risk 
youth and families to reduce 
demand.  
 Police Youth Education Services (YES) includes 
drug education programmes to schools. These 
programmes are delivered to between 550 and 600 
schools each year. 
Ongoing  
Evaluate and, if promising, 
encourage innovative local 
approaches that have 
demonstrated promise for 
reducing demand for 
methamphetamine. 
 Since April 2012, a fourth Hauora Programme 
delivering a seven week intensive 
methamphetamine treatment programme to gangs 
has been completed, and the fifth programme 
commenced.  Training has also been provided to 
graduates to support participants in this fifth 
programme. This fifth programme, with a further 12 
participants, is due to be completed by early 
November 2012.  
Ongoing  
Intervention group 2.5 Strengthen governance 
Improve official coordination of 
drug policy. 
 
 
 The Inter-Agency Committee on Drugs (IACD) is 
responsible for providing oversight of drug policy 
and various action committees (including the 
Precursor Working Group).  
 The IACD is also responsible for overseeing the 
review of the National Drug Policy (NDP). 
 In 2009, the IACD was reformed with tighter 
membership and a more focused work programme 
in an effort to improve coordination and 
governance. Further work is necessary for the 
group to be fully effective.  Ensuring the 
governance framework is robust will be a key to the 
successful review of the NDP. 
Ongoing The Ministry of Health 
has reviewed the 
effectiveness of the 
IACD and has plans 
in place to refresh its 
operation.    
Agencies investigate issues and 
opportunities for Law 
Commission review of the 
Misuse of Drugs Act 1975 
(MoDA). 
 In September 2011 the Government responded to 
the Law Commission's recommendations arising 
from its review of MoDA.  IACD will have oversight 
of any proposed changes to MoDA as a result of 
the review and will report to the Government at a 
later date.   
Ongoing  
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Part 3: Expected results indicators  
3.1 Overview of trends and status  
Indicator Baseline data October 2011 April 2012 October 2012 Change on baseline 
Result: Supply is controlled 
Price1  Median (mean) price per 
point: $100 ($96)  
 Median (mean) price per 
gram: $700 ($698) 
IDMS – 2008 
 No data available.  Median (mean) price 
per point: $100 ($106)  
 Median (mean) price 
per gram: $800 
($815)  
IDMS – 2011 
 No data available The IDMS price data shows a small but statistically 
significant increase in the mean price of a ‘point’ and 
gram of methamphetamine from 2008 to 2011. The 
mean price per gram increased from $698 in 2008 to 
$815 in 2011.  Strong regional variations in prices are 
observed – with Auckland being lower than Wellington 
and Christchurch. 
 Median (mean) price per 
point: $100 ($107)  
 Median (mean) price per 
gram: $700 ($723)  
NZ-ADUM –2010 
 No data available.   Median (mean) price 
per point: $100 ($101)  
 Median (mean) price 
per gram: $800 
($785) 
NZ-ADUM – 2011 
 Median (mean) price per 
point: $100 ($109)  
 Median (mean) price per 
gram: $650 ($686) 
NZ-ADUM – 2012 
There was no significant change in the mean price of 
a point of methamphetamine from 2010-2012. The 
mean price of a gram of meth decreased from $785 in 
2011 to $686 in 2012.  
Prices in Christchurch have changed. The point price 
increased from $110 in 2010 to $125 in 2012, while 
the gram price was down from $1,023 in 2011 to $826 
in 2012. These changes may reflect market shocks 
and recovery from the earthquakes there.    
 
                                                
1 Comparison of NZ-ADUM and IDMS price data should generally be made with caution, as they are drawn from different population samples. The Illicit Drug Monitoring System (IDMS) is an annual survey of 
frequent drug users.  The New Zealand Arrestee Drug Use Monitoring (NZ-ADUM) survey provides information routinely collected from drug users who have been detained by Police in a particular year.  NZ-
ADUM shows two upper North Island sites where methamphetamine is cheaper (i.e. Auckland and Whangarei) whereas the IDMS has one (Auckland). 
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Indicator Baseline data October 2011 April 2012 October 2012 Change on baseline 
Purity  Methamphetamine 
samples were 68.9% 
pure  
ESR 2006-2009 
 100 samples have 
been tested, with purity 
ranging from trace 
amounts (less than 1%) 
to 80%. 73 of the 100 
samples were more 
than 70% pure. 
 Maximum purity for the 
hydrochloride form of 
the drug is 80%. 
ESR report 
 No further testing has 
been carried out. 
 No data available. ESR testing is considered to provide more reliable 
evidence than interviews with drug users.  Purity 
remains high at the wholesale (gram or more) level; 
purity at 'street level' (e.g. a point) has not been 
assessed by ESR yet. 
A proposal to test up to 20 'point' samples is currently 
being considered by ESR.         
 36% of frequent drug 
users reported current 
purity as "high", 7% as 
low.  
 39% reported purity 
currently "fluctuates".  
IDMS – 2008 
 No data available.  33% of frequent drug 
users reported current 
purity as "high", 14% 
as low. 35% reported 
purity currently 
"fluctuates". 
IDMS – 2011 
 No data available Frequent drug users interviewed through the IDMS 
perceive that the current strength of 
methamphetamine has declined slightly from 2008 
(2.3, where 1=low and 3=high) to 2011 (2.2). 14% 
said it was ‘low’ in 2011 compared to 7% in 2008.  
 No data available.  No data available.  No data available.  35% of arrestees reported 
current purity as "high", 13% 
as “low”. 21% reported purity 
currently "fluctuates". 
NZ-ADUM – 2012 
This question is now asked as part of the New 
Zealand Arrestee Drug Use Monitoring survey (to 
supplement the IDMS information). Comparisons 
between different survey results should be made with 
caution due to differences in survey methodologies. 
Availability 
(4 = very easy – 1 = very 
difficult)  
 Average availability 
score 3.3.   
 Change in availability: 
Average score: 1.9.  
 Police report a shortage 
of PSE for production.  
IDMS – 2009 
 No data available.  Average availability 
score 3.1.  
 Change in availability:  
Average score: 2.0. 
IDMS – 2011 
 No data available. The current perceived availability of 
methamphetamine has remained ‘easy/very easy’. 
There was a slight decrease in availability from 3.3 in 
2008 to 3.1 in 2011.  
Declines in availability were more significant in 2008 
to 2011 in Auckland (down from 3.5 to 3.2) and 
Christchurch (down from 3.2 to 2.9). 
 No data available.  No data available.  Average availability 
score 3.0.  
 Change in availability: 
Average score: 2.0. 
NZ-ADUM – 2011 
 Average availability score 3.0. 
 Change in availability: 
Average score: 2.0. 
NZ-ADUM – 2012 
Overall there was no change in availability. However, 
if we examine availability by site we see a decline in 
availability in Auckland, an increase in availability in 
Christchurch (which may represent a recovery in 
availability following the impact of the earthquakes). 
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Indicator Baseline data October 2011 April 2012 October 2012 Change on baseline 
Result: Demand is reduced 
Prevalence (used in last 
12 months)  
 2.2% total NZ population 
16-64 years. 
2007/08 NZ Alcohol and Drug 
Use Survey 
 No data available.  1% total NZ 
population 16-64 
years. This equates to 
approximately 28,000 
New Zealanders. 
 The prevalence of use 
was highest amongst 
those aged between 
18-24 and 25-34 
years. 
NZ Health Survey 
Preliminary findings May-
Dec 2011 
 0.9% total NZ working age 
population. This equates to 
approximately 25,000 New 
Zealander’s 
 Past-year amphetamine use 
was highest amongst 25–34 
year olds (1.9%) and higher 
for males (1.3%) than females 
(0.5%).  
 Past-year amphetamine use 
did not differ significantly by 
ethnic group. 
NZ Health Survey 2011/12 
 
The baseline survey data was re-analysed to ensure 
comparability with the 2011/12 NZ Health Survey. 
Baseline prevalence subsequently increased from 2.1 
to 2.2 percent. 
 
The latest results are a strong indicator of overall 
prevalence reducing.  This is in line with trend. 
 
The 2009 National Household Drug Survey also 
showed a decline in methamphetamine use in the 
population aged 15-45 years (1.4%, down from 3.4% 
in 2006).  However, the use of telephone-based 
interviewing may have resulted in under-
representation of frequent users.  
 
The next New Zealand Health Survey (taking place 
between July 2012 and June 2013) includes a drug 
use module that will provide more robust data for this 
indicator.  Results are due in March 2014.  
Prevalence (used at 
least monthly) 
 0.4% total NZ population 
16-64 years.  
2007/2008 NZ Alcohol and 
Drug Use Survey 
 No data available.  No data available.  No data available. The next New Zealand Health Survey (taking place 
between July 2012 and June 2013) includes a drug 
use module that will provide data for these indicators.  
Results are due in March 2014. 
Prevalence: young 
users (used at least 
monthly) 
 16-17 year olds – 
numbers too low for 
reliable estimation. 
 18-24 year olds – 0.8%. 
2007/2008 NZ Alcohol and 
Drug Use Survey 
 No data available.  No data available.  No data available. 
Mean age of user  No data available.  No data available.  No data available.  No data available. 
Users who report 
reducing their use 
 Mean use of 38 days in 
past 6 months in 2008 
(68 days in 2007). 
2009 IDMS 
 No data available.  Mean use of 40 days 
in past 6 months in 
2011. 
2011 IDMS  
 No data available. Mean days of methamphetamine use have fallen 
since the 2010 baseline. This continues an overall 
downward trend in use that has been occurring since 
2007.  
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Indicator Baseline data October 2011 April 2012 October 2012 Change on baseline 
Result: Fewer frequent users 
Levels of use   39% of frequent 
methamphetamine users 
were using less and 
13% had stopped.  
2009 IDMS 
 29% of frequent 
methamphetamine 
users were using less 
and 5% had stopped. 
2010 IDMS 
 41% of frequent 
methamphetamine 
users detained by 
Police were using less 
and 8% had stopped. 
2011 NZ-ADUM 
 No data available. This question was not asked in the 2011 IDMS survey 
due to concerns about its validity, so NZ-ADUM data 
is presented instead. However, data between the 
surveys may not be comparable due to different 
sample populations (frequent drug users vs. Police 
detainees). 
Methamphetamine 
related convictions2 
 Convictions for 
possession/use: 1,188. 
 Convictions for 
supply/deal (including 
import/export): 423. 
 Convictions for 
manufacture: 514. 
 Total convictions: 2,125 
(2008). 
Ministry of Justice Case 
Management System 
 Convictions for 
possession/use: 1,401 
 Convictions for 
supply/deal (including 
import/export): 1,123 
 Convictions for 
manufacture: 468 
 Total convictions: 2,992 
(2010). 
Ministry of Justice Case 
Management System 
 Court data for 2011 is 
not available until 
June 2012. This 
information will be 
provided in the 
October 2012 report.   
 
 Convictions for 
possession/use: 1,187 
 Convictions for supply/deal 
(including import/export): 860 
 Convictions for manufacture: 
413 
 Total Convictions: 2,460 
(2011). 
Ministry of Justice Case 
Management System 
Baseline and 2010 numbers have changed slightly 
due to the completion of trials, including appeals over 
the last year. 
 
There has been a significant increase in the total 
number of convictions since 2008, largely due to the 
increase in supply/deal convictions.  Convictions for 
possession have remained relatively stable, while 
there has been a decrease in convictions for 
manufacture.    
Users who have 
received treatment 
report a reduction in 
drug use/frequency of 
use 
 Average days per month 
of amphetamine use 
before treatment: 8.7 
days.  
Ministry of Health, 2010 
 No data available.  Average days per 
month of 
amphetamine use pre-
treatment was 7.4 
days. 
 Average days per 
month of 
amphetamine use one 
month after 
completing treatment: 
1.1 days.  
Ministry of Health 
 Average days per month of 
amphetamine use pre-
treatment was 7.4 days. 
 Average days per month of 
amphetamine use one month 
after completing treatment: 
0.9 days. 
Nov 2009 to June 2012, Ministry of 
Health 
Due to the small number of clients seeking treatment and 
the inability to maintain contact with clients post-treatment, 
it is difficult to reliably comment on trends in drug use 
post-treatment. 
                                                
2 A change in reporting criteria means conviction data vary slightly from those provided in the previous update report. Please see Appendix 1 for an explanation of the change. 
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3.2 Methamphetamine supply is controlled 
3.2.1 Summary 
Definition 
 
Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
Indicator: Price 
Price per point (10th of a 
gram) and price per gram 
of Methamphetamine 
 $100 per point. 
 $800-1,000 per gram. 
Sept 2009  $100 per point. 
 $842 is the mean 
price for a gram 
although there are 
significant variations 
in the price range 
reported. 
Feb-May 2012 Police and Customs 
intelligence reports 
received by the NDIB. 
Police gather price 
details from a variety 
of sources including 
interviews/discussion 
with users and 
informants. 
Successful supply 
control leads to an 
increase in price. 
Price changes are 
usually temporary. 
Police reporting 
indicates that prices 
remain relatively 
stable except in the 
upper North Island 
region, where there 
appears to have 
been an increase in 
reports of lower 
($600 or below) 
gram prices.3  It is 
likely that 
methamphetamine 
being sold at 
cheaper prices is of 
lower purity, or not 
a full gram, or 
reliant on the 
dealer-buyer 
relationship. Pricing 
of 
methamphetamine 
at the ounce and 
point level tends to 
remain relatively 
stable. 
                                                
3 NDIB pricing data is primarily dependent upon the submission of details obtained from persons arrested in relation to drug offences. As such the sources (and their reliability) vary. The reported prices can 
also be affected by regional variations and a small reporting sample. It is recommended that these prices are considered indicative only until verified by further reporting. 
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Definition 
 
Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
Price per point (10th of a 
gram) and price per gram 
of methamphetamine 
 Median price per point: 
$100. 
 Mean price per point: 
$96 (n=166). 
 Median price per gram: 
$70. 
 Mean price per gram: 
$698 (n=54). 
2008  Median price per 
point: $100.  
 Mean price per point: 
$106 (n=161). 
 Median price per 
gram: $800.  
 Mean price per gram: 
$815 (n=69). 
2011 IDMS Successful arrests 
and seizures lead to 
high prices. 
There have been 
increases in the 
price of both a point 
and a gram of 
methamphetamine 
in recent years. The 
mean price of a 
gram increased 
from $698 in 2008 
to $815 in 2011. 
However, there is 
significant regional 
variation, and there 
has been some 
levelling out of price 
in 2011 compared 
to 2010.   
Price per point (10th of a 
gram) and price per gram 
of methamphetamine  
 
 Median (mean) price per 
point: $100 ($107) 
(n=156). 
 Median (mean) price per 
gram: $700 ($723) 
(n=71). 
 
2010  Median (mean) price 
per point: $100 
($109) (n=154). 
 Median (mean) price 
per gram: $650 
($686) (n=83). 
 
2011 NZ-ADUM  The slight rise in 
point price was 
largely due to an 
increase in 
Christchurch (up 
from $110 in 2010 
to $124 in 2012). 
The decline in the 
gram price was also 
influenced by a 
decline in 
Christchurch (down 
from $1,023 in 2011 
to $826 in 2012). 
The changes in 
Christchurch may 
reflect market 
shocks and 
recovery from the 
earthquakes.  
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Definition 
 
Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
Price per capsule or 
equivalent of 
pseudoephedrine in the 
illegal market (not over 
the counter purchase 
price) - Police Data 
 A set of ContacNT 
(equivalent to 1,000 
capsules) $12,000 - 
$16,000. 
 1 packet ContacNT (10 
capsules) - $90-$100. 
 1 packet domestically 
sourced PSE (24 
tablets) - $100. 
Sept  2009  Prices range from 
$8,000-$14,000. 
Feb-May 2012 NDIB Successful 
restriction leads to a 
rise in price. 
Pricing reports 
relating to 
pseudoephedrine 
are very limited, 
and caution should 
be exercised in 
interpreting results.  
 
Indicator: Purity 
Perception of overall level 
of purity as reported by 
frequent drug users 
 36% of frequent drug 
users reported current 
purity as "high", 7% as 
low. 39% reported purity 
currently "fluctuates".  
 48% reported purity in 
the last six months was 
"fluctuating", 29% said 
purity was “stable” over 
that time. 
2008  35% of frequent drug 
users reported 
current purity as 
"high", 13% as low. 
21% reported purity 
currently "fluctuates". 
 24% reported purity 
in the last six months 
was "fluctuating", 
42% said purity was 
“stable” over that 
time. 
2011 IDMS Successful supply 
control leads to a 
decrease in purity. 
Frequent drug 
users interviewed 
through the IDMS 
perceive that the 
current strength of 
methamphetamine 
has declined 
slightly from 2008 
(2.3, where 1=low 
and 3=high) to 2011 
(2.2). 14% said it 
was ‘low’ in 2011 
compared to 7% in 
2008. 
Methamphetamine 
percentage in seized 
samples, tested by ESR  
 68.9% 2009   73% of samples 
tested contained 
methamphetamine 
with a purity of 70% 
or higher (80% is 
the highest possible 
purity due to 
manufacturing 
methods).  
 The median 
methamphetamine 
April - Sep 2011 ESR Pilot Drug 
Signature 
Programme Final 
report, August 2011. 
 Purity, as 
established by 
forensic testing, 
remains high at 
the wholesale (a 
gram or more) 
level. 
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Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
purity across all 
samples was 75%. 
Indicator: Availability 
Overall availability of 
methamphetamine as 
reported by frequent 
drug users 
 
 
 
 
 
 
 
 42% of frequent drug 
users reported the 
availability of 
methamphetamine 
was “very easy”. 
 0% reported it was 
“very difficult”. 
 Average availability 
score 3.3.   
2008  32% of frequent 
drug users reported 
the availability of 
methamphetamine 
was “very easy” 
 2% reported it was 
“very difficult” 
 Average availability 
score 3.1 
 
2011 IDMS Successful supply 
control leads to 
more difficulty 
obtaining meth-
amphetamine.  
 
There has been a 
slight decline in 
the current 
availability of 
methamphetamine 
from 2008 to 2011 
(down from 3.3 in 
2008 to 3.1 in 
2011, where 
1=very difficult 
and 4=very easy).  
 
Almost all police 
reporting suggests 
that 
methamphetamine 
remains widely 
and easily 
available. 
 
Change in availability of 
methamphetamine over 
the last six months as 
reported by frequent 
drug users 
 Change: 23% of users 
reported 
methamphetamine 
becoming more difficult 
to get, 57% reported 
no change in 
availability, 14% 
reported easier.  
 Average change score: 
1.9. 
2008  Change: 16% of 
users reported 
meth-amphetamine 
becoming ‘more 
difficult’ to get, 53% 
reported no change 
in availability, 18% 
reported ‘easier’.  
 Average change 
score: 2.0 
 
 
 
2011 IDMS   
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Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
Qualitative information 
from enforcement 
agencies 
 There is a shortage in 
illicitly imported PSE-
based medications 
intended for the 
production of 
methamphetamine 
within NZ, according to 
Police reports. 
Mid-late 2009  No further 
shortages reported. 
2012 NDIB  The limited new 
information that 
has been received 
on EPH/PSE 
indicates 
availability 
remains relatively 
stable. 
 
Price trends 
Prices for methamphetamine (IDMS) 
Methamphetamine  price 
Median (mean) 
2007 2008 2009 2010 2011 2012 
1 Point   $100 ($97) $100 ($96) $100 ($100) $100 ($104) $100 ($106) No data available 
1 Gram  $600 ($676) $700 ($698) $700 ($738) $800 ($780) $800 ($815) No data available 
Source: IDMS for 2007-2011 
 
 
3.3 Demand for methamphetamine is reduced    
Indicator Description Baseline data Period Latest data  
(at October 2012) 
Period 
 
Source Desired direction Change in indicator and 
notes 
Prevalence  
(last 12 months)  
Users of amphetamines, 
including 
methamphetamine as a 
percentage of the 16-64 
population in the past 12 
months. 
2.2% 2007/08 The 2011/12 New Zealand 
Health Survey shows a 
prevalence rate of 0.9% for 
the 16-64 age group. 
 
The result was higher for 
males (1.3%) than females 
(0.5%). 
2011 New Zealand 
Alcohol and 
Drug Use 
Survey 
(2007/08) 
 
New Zealand 
Health Survey 
(2011/12) 
Successful demand 
reduction and problem 
limitation measures lead to 
a decrease in percentage 
of population using 
methamphetamine. 
Two different surveys have 
been used to provide 
prevalence information.  Data 
from the New Zealand 
Alcohol and Drug Use Survey 
(2007/08) was re-analysed to 
enable comparison of results. 
Prevalence (used at 
least monthly) 
Users of amphetamines, 
including 
methamphetamine as a 
0.4% 2007/08 No data available. N/A New Zealand 
Alcohol and 
Drug Use 
Successful demand 
reduction and problem 
limitation measures lead to 
The next New Zealand 
Health Survey (taking place 
between July 2012 and June 
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Indicator Description Baseline data Period Latest data  
(at October 2012) 
Period 
 
Source Desired direction Change in indicator and 
notes 
percentage of the 16-64 
population who used at 
least monthly in the past 
year.  
Survey a decrease in percentage 
of population using 
methamphetamine. 
2013) includes a drug use 
module that will provide 
robust data for this indicator.  
Results are due in March 
2014. Prevalence: young 
users (used at least 
monthly) 
16-17 year old users as 
a percentage of the 16-
64 population who used 
at least monthly. 
Numbers too 
low for reliable 
estimation. 
2007/08 No data available. N/A New Zealand 
Alcohol and 
Drug Use 
Survey 
A reduction in younger 
users is likely to result in 
fewer new users overall 
and an aging user 
population.  
 
18-24 year old users as 
a percentage of the 16-
64 population who used 
at least monthly. 
0.8% 2007/08 No data available. N/A New Zealand 
Alcohol and 
Drug Use 
Survey 
Mean age of user Mean age of monthly 
using population. 
No data 
available. 
2007/08 No data available. N/A N/A Successful demand 
reduction measures lead to 
an upward shift in the age 
of the using population, as 
this suggests there are 
fewer new people using 
methamphetamine. 
Users who report 
reducing their use 
Frequent users reporting 
number of days 
methamphetamine used 
in the past six months.  
Mean use of 38 
days in past 6 
months in 2008 
(68 days in 
2007). 
2008 Mean use of 40 days in past 
6 months in 2011 (45 days in 
2010). 
2011 IDMS Lower mean number of 
days in past 6 months. 
Mean days of 
methamphetamine use have 
increased slightly since the 
2008 baseline.  However, 
longer term data shows that 
an overall downward trend in 
use has been occurring since 
2007.
 
  
 
Tackling M
etham
phetam
ine: Indicators and P
rogress R
eport O
ctober 2012 
20
P
O
LIC
Y
 A
D
V
IS
O
R
Y
 G
R
O
U
P
Age distribution of users 
Percentage of the New Zealand population aged 16–64 years, by age group and gender that used amphetamines 2007 
 Age group Prevalence (%) (95% CI)  
Note the 2007/08 baseline data (shown left) was re-analysed to enable 
comparison with 2010/11 survey data. Baseline prevalence increased from 2.1 to 
2.2 percent as a result.  
   
It was not possible to re-analyse prevalence by age group or gender due to the 
low number of reported users. However, general trends indicate:  
 past year amphetamine use is now highest amongst 25-34 year olds, 
compared with 18-24 year olds in the 2007/08 survey  
 prevalence continues to be higher amongst males than females 
The 2011/12 survey also indicates that prevalence does not differ significantly 
between ethnicity groups. 
 
Total Men Women 
 16–17 years 1.4 – 2.8 
18–24 years 5.8 8.4 3.4 
25–34 years 3.2 4.1 2.5 
35–44 years 1.8 2.8 0.8 
45–54 years 0.6 0.9 0.3 
55–64 years – – – 
Total aged 16–64 years 2.1 2.9 1.4 
 
Source:  Results from the 2007/08 New Zealand Alcohol and Drug Use Survey, Chap 5: Stimulants/Amphetamines. Ministry of Health 
Notes: A dash (–) indicates that numbers were too low for reliable estimation.  
3.4 There are fewer frequent users 
Indicator Description Baseline 
data 
Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and 
notes 
Levels of use Changes in 
methamphetamine use of 
frequent drug users who 
reported using 
methamphetamine in the 
past six months. 
21% using 
‘more’; 28% 
‘the same’; 
39% ‘less’ 
and 13% 
‘stopped’ in 
2009. 
2009 32% using ‘more’; 19% 
‘the same’; 41% ‘less’ 
and 8% ‘stopped’ in 
2011. (NZ-ADUM)  
2011 IDMS for 
baseline 2009. 
 
NZ-ADUM for 
2011 data.  
Successful demand reduction 
and problem limitation 
measures lead to a decrease 
in levels of use. 
This question was not 
asked in the 2011 IDMS 
survey due to concerns 
about its validity, so NZ-
ADUM data is presented 
instead. However, data 
between the surveys may 
not be comparable due to 
different sample 
populations (frequent drug 
users vs. Police 
detainees).  
Methamphetamine-
related convictions 
Total convictions for:   
a) possession/use 
b) supply/deal (including 
a) 1,188 
b) 423 
c) 514 
2008 a) 1,187 
b) 860 
c) 413 
2011 Ministry of 
Justice's Case 
Management 
Successful demand reduction 
and problem limitation 
measures lead to a decrease 
Baseline and 2010 
numbers have changed 
slightly due to the 
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Indicator Description Baseline 
data 
Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and 
notes 
import/export) 
c) manufacture/ 
possession of 
equipment to 
manufacture 
d) all categories combined. 
 
The two key indicators are 
a) and d). 
d)  2,125 d) 2,460 System in convictions for possession 
and use; an initial increase in 
convictions for supply, 
dealing and manufacture. 
completion of trials, 
including appeals over the 
last year. 
Users who have 
received treatment 
report a reduction in 
drug use/frequency 
of use 
Reports from users 
receiving treatment from 
dedicated drug treatment 
services. 
Average days 
per month of 
amphetamine 
use before 
treatment: 8.7 
days. 
2010 Average days per month 
of amphetamine use pre-
treatment was 7.4 days. 
 
Average days per month 
of amphetamine use one 
month after completing 
treatment: 0.9 days. 
Nov 2009 
to March 
2012 
 
 
Ministry of 
Health  
Successful problem limitation 
measures lead to a reduction 
in drug use/frequency of use.  
It is encouraging to note 
there is a marked drop-off 
1 month after treatment. 
However, there is a small 
increase in use at 3 
months post-discharge. 
This is not surprising as 
some people can 
relapse/resume use. A 
message for treatment 
providers is that longer 
term support post 
discharge needs to be in 
place. Some 21 clients 
have been traced 12 
months after completing 
treatment. The average 
numbers of days of 
amphetamine use 
decreased from 5.5 days 
to 1.1 days for these 
clients. 
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Methamphetamine related hospital admissions 
The table below indicates that hospital admissions for methamphetamine-related causes have increased overall since recording began in July 2008 (prior to this 
methamphetamine was included among 'stimulants' in hospital admissions), but there is no discernible trend, with admission numbers fluctuating. Any increase could 
be due to, riskier drug-taking practices or impurities/other psychoactive substances in the methamphetamine, or more willingness by users to seek medical help. The 
main reasons people are hospitalised for methamphetamine use are psychotic disorder or other mental and behavioural disorders as a result of, or related to, 
methamphetamine use.  
 
Data is collected from publicly-funded hospitals only, and does not include figures from the emergency departments. The actual numbers of people admitted with 
methamphetamine-related disorders is higher than those noted below; however, accurate trend analysis requires the removal of a number of records.4   
 
Hospital admissions for Methamphetamine trend analysis Jul - Dec  
2008 
Jan - Jun 
2009 
Jul - Dec 
2009 
Jan - Jun 
2010 
Jul-Dec 
2010 
Jan-Jun 
2011 
Jul – Dec 
2011 
Jan-Jun 
2012 
Primary Diagnosis5 21 23 32 31 21 22 36 31 
Secondary diagnosis 49 83 65 85 97 80 91 111 
Total  70 106 97 116 118 102 127 142 
Calendar year N/A 203 234 229 N/A 
 
Analysis of data for the period July 2008 – December 2010 showed that most of the admissions were in hospitals in the upper North Island, particularly Auckland. 
New Zealand/Europeans accounted for 50% of all methamphetamine admissions, followed by Maori, who were significantly over-represented at 42% and Pacific 
Islanders at 4%. Seventy-one percent were aged between 20 and 39 (55% between 20 and 34), with the largest single age-group (by a small margin) being those 
aged 30-34 (20%). Only 10% of admissions were for people aged 19 or younger.
                                                
4 Between 2000 and 2010, hospital admission policies were not consistent between hospitals or for the same hospitals over a period time.  Some emergency department patients were admitted to hospital as 
a rule if they have been in the ED for three hours, which meant that hospital admission numbers appeared to increase significantly, when in fact it reflected a change in admission policies.  To counter this and 
ensure accurate trend data, the figures shown here do not include short-stay admissions from emergency departments.  Therefore the actual numbers of people admitted with methamphetamine related 
disorders is higher than noted here (by approximately a third), but these admissions have not been included as they skew the data. 
5 The primary diagnosis is the one established to be chiefly responsible for causing the patients' episode of care in hospital.  The secondary diagnosis is a condition or complaint either co-existing with the 
primary diagnosis or arising during the episode of care. 
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Number of methamphetamine related convictions 
The charts below show methamphetamine convictions and recorded offences by category for the last six years. Note that the supply/deal category includes 
import/export of methamphetamine. 
Methamphetamine convictions and recorded offences by category6 
Methamphetamine 
convictions 
2005 2006 2007 2008 2009 2010 2011 
 Recorded 
offence 
Conviction Recorded 
offence 
Conviction Recorded 
offence 
Conviction Recorded 
offence 
Conviction Recorded 
offence 
Conviction Recorded 
offence 
Conviction Recorded 
offence 
Conviction 
Possession and/or 
use  
1,694 984 2,133 1,369 1,988 1,325 1,653 1,188 2,007 1,372 1,850 1,401 1784 1187 
Supplying and/or 
dealing  
351 208 344 271 321 272 437 423 569 433 754 1,123 524 860 
Manufacturing 
and/or in 
possession of 
equipment for 
manufacture 
409 541 443 363 480 381 448 514 524 481 420 468 300 413 
Total 2,454 1,733 2,920 2,003 2,789 1,978 2,538 2,125 3,100 2,286 3,024 2,992 2608 2,460 
There is no direct link between the charges laid and convictions finalised for any given year. The total number of convictions for each year represents convictions that 
were received that year. They include convictions that have yet to be (or will not be) appealed and convictions that have been finalised following exhaustion of appeal 
options for each individual case. The figures are therefore subject to adjustment each subsequent year as case outcomes are finalised.  
 
                                                
6 Source: Ministry of Justice Case Management System  
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   Supply/dealing methamphetamine convictions, 2004-2011 
   
 
All methamphetamine convictions, 2004-2011 
Possession/use of methamphetamine convictions, 2004-2011 
 
 
Manufacture/equipment methamphetamine convictions, 2004-2011  
  
  
 Source: Ministry of Justice Case Management System        
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Part 4: Intermediate results indicators 
4.1 Manufacturers can’t access the products necessary to make methamphetamine 
Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and 
notes 
Clan lab busts and 
information on 
substances found in 
clan labs 
The number of 
clandestine laboratories 
detected and 
dismantled by Police. 
176 (43 clan lab 
assessments made 
and 133 clan labs 
dismantled). 
2008 146 (79 assessments 
& 65 clan labs 
dismantled).  
 
1 Jan 2012-
30 
September 
2012 
NDIB, from 
National 
Clandestine 
Laboratory 
Response Team 
reporting. 
Successful supply 
control would result 
in a decrease in 
clan labs 
discovered that 
coincided with a 
decrease in 
methamphetamine 
availability. 
However, in the 
interim, rising clan 
lab busts are also a 
measure of 
enforcement 
success.  
In the 2012 year to date, 
there has been a 12% 
decrease in the number of 
clan labs dismantled and a 
27% increase in clan lab 
assessments, compared with 
the same period in 2011.  
85% of all clan labs 
dismantled so far in 2012 
were found in the upper 
North Island (from Waikato 
and Bay of Plenty areas to 
Northland).  
Information about 
ease of manufacture 
Qualitative information 
about 
methamphetamine 
manufacture sourced 
from Police. 
There appears to be 
a  current shortage 
in illicitly imported 
pseudoephedrine-
based medications 
intended for the 
production of 
methamphetamine 
within New Zealand. 
Sept 
2009 
Following proactive 
Police engagement, 
some retailers 
(hardware stores) are 
restricting bulk sales of 
key manufacturing 
chemicals. 
 
 
April 2012 NDIB monthly 
reporting. 
Successful supply 
control would result 
in more difficulty in 
manufacturing 
and/or obtaining the 
precursors required 
to manufacture. 
A restriction of manufacturing 
chemicals appears to be 
impacting on the ease with 
which manufacturers can 
make methamphetamine. 
However, Police reporting 
indicates manufacture 
remains widespread, with a 
higher prevalence in the 
upper North Island.   
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Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and 
notes 
Seizures of 
methamphetamine 
and PSE  
Ephedrine and 
pseudoephedrine 
seizures over the past 
12 months.7 
5,586,330 tablets 
(1,245,751 grams). 
Sept 
2008 – 
Aug 2009 
385,563 
grams (345,470 grams 
Customs & 40,093 
grams Police). 
 
September 
2011 – 31 
August 
2012 
 
 
 
 
NDIB (Police 
and Customs) 
 
 
 
 
 
 
Successful supply 
control would result 
in an increase in 
seizures, in the 
interim, and 
eventually a long 
term decrease in 
seizures. 
In the 2011 calendar year, 
there was a 37% reduction in 
the amount of 
ephedrine/pseudoephedrine 
seized compared to the 
previous year. Seizures in 
2012-to-date remain 
comparatively low; with a 
69% drop in the quantity of 
seized in comparison to the 
same time period in 2011. 
Number of precursor 
seizures over the last 12 
months. 
878 seizures. Sept 
2008 – 
Aug 2009 
510 (472 Customs & 
38 Police). 
 
September 
2011 – 31 
August 
2012 
 
NDIB (Police 
and Customs) 
 There has been a 47% 
decrease in the number of 
seizure incidents in 2012 
compared to the same period 
in 2011. 
Methamphetamine 
seizures by Police and 
Customs. 
22,106 grams. 2008 18,432.25 grams 
(4,774.02 grams 
Customs and 
13,658.23 grams 
Police). 
September 
2011 – 31 
August 
2012 
 
NDIB (Police 
and Customs) 
 Seizures of 
methamphetamine are down 
83% compared to the same 
period last year. While Police 
seizures have remained 
relatively consistent a decline 
in seizures at the border has 
a significant impact on the 
total quantity of 
methamphetamine seized. 
Number of 
methamphetamine 
seizures by Police and 
Customs. 
546 seizures. 2008 1,023 seizures (1,004 
Police & 19 Customs). 
September 
2011 – 31 
August 
2012 
 
NDIB (Police 
and Customs) 
 There has been an 89% 
decrease in seizures 
compared to the same period 
last year. 
                                                
7 This field previously only measured seizures at the border; this has been changed to include domestic seizures (by Police) as well, to ensure a more accurate portrayal of the data available. 
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Amount seized - converted to  90mg tablets (equivalent) Number of incidents
 
Year 2005  2006  2007  2008 2009  2010  
 
2011 2012 
(1 Jan–30 
September 
2012) 
Amount seized (tablets) - converted to 
equivalent of 90mg tablets 
1,664,228 2,667,068 1,766,200 3,336,978 5,392,886 4,383,594 2,789,964 1,371,668 
Equivalent in kilos of precursors 371 594 393 744 1203 978 622 329 
Number of seizures 678 284 454 831 923 788 686 287 
Potential methamphetamine yield (kilos) 74 - 104 120 - 168 79 - 111 150 - 210 242.5 - 340 197 - 276 126 - 176 62 - 86 
Source: Customs 
 2012 statistics are year to date from 01 Jan 2012 to 30 September 2012 (table and chart). These are preliminary figures and yet to be confirmed. 
 Methamphetamine yield is calculated on 50%-70% purity. 
 Interceptions are subject to change due to circumstances, such as quantities being updated as substances are further tested or the drugs being reweighed as the relevant investigation proceeds to prosecution. 
 The information contained in this document has been obtained from the New Zealand Customs Service CusMod database. The information is considered correct at the time/date the data was extracted (October 
2012). Please note the information contained within CusMod may be amended or reviewed at any time. 
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Seizures of methamphetamine (Police and Customs) 
Year 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 YTD 
Methamphetamine (grams) 2,631 7,720 3,632 28,460 30,693 121,838 39,304 19,300 20,779 30,900 53,891 7,510* 
Number of seizures N/A N/A N/A N/A N/A 673 468 666 763 833 1064 734* 
* Figures up to 30 September 2012 
 
 
 
Source: NDIB (Police and Customs data)
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4.2 People are deterred from the methamphetamine trade 
Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
Methamphetamine 
supply convictions 
Convictions for 
supplying/dealing in 
methamphetamine 
(including importing and 
exporting); and convictions 
for manufacturing or 
possessing the equipment 
to manufacture 
methamphetamine.  
Supplying/dealing 
convictions:  423. 
Manufacturing convictions:      
514. 
2008 Supplying/dealing 
convictions:  860. 
Manufacturing convictions:    
413. 
2011 Ministry of 
Justice 
Case 
Management 
System  
Expect to see an initial 
increase in supply 
convictions as 
methamphetamine 
enforcement is given high 
priority and then a 
decrease as deterrent 
effect occurs. 
 
Numbers of repeat 
offenders 
Offenders convicted of 
methamphetamine 
offences since 1997, who 
reoffend in subsequent 
years. Two offences in the 
same year are not 
classified as re-offences.   
In 2008, 1,208 offenders 
were convicted for 
methamphetamine offences. 
Of these, 267 (or 22.1%) 
were individuals previously 
convicted of a 
methamphetamine offence 
and 189 (or 15.6%) 
previously charged but not 
convicted. 
2008 In 2011, 1,214 offenders 
were convicted for 
methamphetamine 
offences. Of these, 393 (or 
32.4%) were individuals 
previously convicted of a 
methamphetamine offence 
and 147 (or 12.1%) 
previously charged but not 
convicted. 
2011 Ministry of 
Justice  
Case 
Management 
System 
Expect to see an initial 
increase in supply 
convictions as 
methamphetamine 
enforcement is given high 
priority and then a 
decrease as deterrent 
effect occurs. 
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Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
Qualitative 
information about 
supply chains 
Description of 
methamphetamine supply 
chains, including 
importation, manufacture, 
distribution and retail. For 
example: 
 changes in 
manufacturing 
methods 
 size of labs detected 
 trend of lab 
detections for the last 
6 months 
 pattern of seizures 
(e.g. multi-kilo or 
small seizures). 
While ContacNT from China 
remains the dominant 
precursor encountered by 
Customs there are signs of 
an increasing divergence of 
sources and trafficking 
routes for 
methamphetamine 
precursors. 
There are reports of New 
Zealand drug manufacturers 
having difficulty in obtaining 
PSE products. 
2009 While China and Hong 
Kong remain the main 
export points for precursors, 
there continues to be a 
number of secondary tier 
sources including South-
East Asia, North America 
and Europe.   
No further reports of 
shortages. 
Recent operational activity 
indicates new trends in the 
receipt of 
ephedrine/pseudoephedrine 
shipments and traffickers 
becoming more responsive 
to law enforcement 
interventions. 
Oct 
2011 – 
March 
2012 
 
Customs & 
NDIB 
 
N/A  This has partly 
been covered in 
section 4.1 
'Information about 
ease of 
manufacture’. 
 
Law enforcement 
agencies note the 
on-going role of 
trans-national 
organised criminal 
groups in the 
importation, 
manufacture and 
supply of 
methamphetamine 
in NZ. 
Methamphetamine supply chains 
 Pseudoephedrine (PSE) is mainly 
sourced from China and brought to NZ 
illegally by passengers and in cargo, 
fast freight and mail, often by OCGs  
Gangs & OCGs 
organise 
manufacture  
with imported PSE  
in clan labs 
Methamphetamine (finished product) 
is brought into New Zealand illegally 
by passengers and in cargo, fast 
freight and mail, often by OCGs 
Traffickers use layers of clean skin 
“catchers” to pick up & sell to gangs 
Gangs & 
OCGs 
distribute 
product 
Individuals (often controlled by 
gangs and OCGs) “cook” meth-
amphetamine with PSE locally 
sourced by pill shoppers 
Methamphetamine is sold through retail dealers 
Gang organised pill-shoppers 
source PSE from NZ pharmacies 
Users may become involved in sale  
and manufacture to fund use 
Users find methamphetamine through  
their social networks 
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4.3 The ability to generate profits is reduced 
Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in 
indicator and 
notes 
Dollars and assets 
recovered from 
organised crime 
Dollars and 
assets 
recovered from 
organised crime. 
Approximately $1.8 million 
was recovered in 2007/08 
under the legislation. 
At the end of the last financial 
year approximately $41 
million was under Police 
Proceeds of Crime action.  
In future it will be reported 
through the Police 
Methamphetamine Control 
Strategy.   
Annual  Since the Criminal Proceeds (Recovery) Act 
(CPRA) came into effect in December 2009, 
New Zealand Police have investigated an 
estimated $208 million worth of assets 
suspected to have been obtained through or 
derived from criminal activity. 
 
As at 30 September 2012 New Zealand 
Police held Restraining Orders over an 
estimated $106 million worth of assets 
believed to have been obtained through or 
derived from criminal activity.  An additional 
estimated $18.5 million worth of assets have 
been made subject to Forfeiture Orders. 
Investigations are on-going in many other 
cases. 
 
Of the estimated $208 million investigated, an 
estimated $136 million is attributed to drug 
offending; $57.4 million of this relates 
specifically to methamphetamine offending. 
1 
December 
2009 – 30 
September 
2012 
 
 
Police 
Financial 
Crime Group 
 
 
 The restraint and 
forfeiture of assets 
acquired and 
derived from drug 
offending is proven 
to act as a 
deterrent to criminal 
behaviour as well 
as eroding the 
economic base of 
offenders, reducing 
their ability to fund 
further crime. The 
CPRA has provided 
New Zealand with 
effective legislation  
with which to tackle 
drug offending, and 
the high levels of 
success that have 
been achieved 
since the CPRA 
came into effect are 
expected to 
continue for the 
foreseeable. 
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4.4 Communities are aware of risks 
Indicator Definition Baseline data Period Latest data 
(at October 
2012) 
Period  Source Desired direction Change in indicator and notes 
Drug use knowledge 
and attitudes survey 
New Zealanders’ attitudes 
to illegal drugs and drug 
use. 
94% of respondents 
said that 
methamphetamine is a 
drug causing serious 
harm (compared with 
58% for cannabis and 
39% for alcohol). 
2008 Data is not 
available for 
2011. 
N/A Ministry of 
Health 
Increased awareness of 
effects of 
methamphetamine use 
and how to access 
help/support.  
 
Use of website with 
methamphetamine 
information and 
resources 
Methamphetamine-
specific resources (e.g. 
print, DVD) to be 
developed as part of 
development of Drug 
Information and Help 
website.  
11,451 visits to 
DrugHelp and 3,164 to 
MethHelp. 
 
Nearly 4,000 copies of 
the MethHelp booklet 
have been distributed. 
August 
2010 –
February 
2011 
25,000 visits 
to MethHelp. 
 
Orders 
received for 
10,000  
MethHelp 
booklets. 
Aug 2010 
– 
September 
2012 
 
Ministry of 
Health  
Drug Information and 
Help website will provide 
information on site visits 
relating to 
methamphetamine 
component and a 
potential survey of those 
accessing 
methamphetamine 
information. 
MethHelp and DrugHelp engage with 
the audience through the use of 
genuine stories from New Zealanders 
who have "been there".  
There have been more than 9,000 
visits to the MethHelp site since the 
April 2012 report.  
The interrelationship between the 
various treatment initiatives is 
demonstrated by the way MethHelp 
generates a significant number of 
calls to the AlcoholDrug Helpline. It 
also encourages people to contract 
treatment agencies, particularly 
through the recently completed 
“Treatment Options” section. The 
MethHelp DVD is used extensively in 
community settings through CAYAD’s 
and other community providers. 
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4.5 Users know how to find help 
Indicator Definition Baseline data Period  Latest data  
(at October 2012) 
Period  Source Desired 
direction 
Change in 
indicator and 
notes 
Percentage of frequent 
users who sought help but 
did not receive it 
Percentage of frequent users who 
reported they sought help but did not 
receive it.   
22% of frequent users in 2008 
(32% in 2007). 
2008 29% of frequent users in 
2011 (24% in 2010). 
2011 IDMS    No change in 2011 
compared to the 
previous three 
years. 
Awareness of Alcohol Drug 
Helpline 
Awareness of Alcohol Drug helpline 
by methamphetamine users.  
1,256 methamphetamine 
related calls, including 424 
self-calls and 832 concerned 
other calls. 
2008/09 2,800 methamphetamine 
related calls since Nov 
2009.  Over 1,000 of 
those have been 
concerned about their 
own use, and nearly 
2,000 have been calls 
concerned about 
someone else’s use.  
to 30 
September 
2012 
Alcohol 
Drug 
Helpline 
Higher 
number of 
calls to 
Helpline. 
Demand for 
Helpline services 
remains high and 
consistent. Overall 
there hasn’t been 
any significant 
change in patterns 
over this period 
other than an 
increase in calls 
from adult children 
with regards to 
their parent’s use 
of 
methamphetamine. 
Self-callers within 
the 40–60 age 
group also appear 
to be more highly 
represented than 
previously.   
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4.6 Communities and government agencies help users into treatment 
Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and notes 
Frequent users who 
report they are 
receiving some 
form of drug 
treatment 
Frequent 
methamphetamine 
users who report they 
are receiving some 
form of drug 
treatment. 
21% of frequent 
methamphetamine 
users were currently in 
drug treatment. 
2008 17% of frequent 
methamphetamine 
users were currently in 
treatment in 2011 
(17% in 2010). 
2011 IDMS  Increase as a measure 
of availability of 
treatment services; 
decrease as a 
measure of need for 
treatment, as 
prevalence decreases. 
There was no change in the proportion of 
frequent methamphetamine users who 
were currently in drug treatment in 2011 
compared to 2010 (17% in both years). 
There was also no change in proportion 
currently receiving treatment from 2008 to 
2010 (21% to 17%). It is important to note 
that to be eligible to be interviewed for the 
IDMS you have to be a current frequent 
drug user. This requirement tends to bias 
against those in treatment as treatment 
requires drug abstinence. 
Barriers to frequent 
users being able to 
access treatment 
Frequent 
methamphetamine 
users report barriers 
to being unable to find 
help for their drug 
use. 
22% of frequent users 
reported barriers to 
finding help, including: 
 fear of what 
might happen 
once contact 
made with 
service (45%) 
 social pressure to 
keep using (36%) 
 fear of losing 
friends (34%) 
 fear of police 
(27%) 
 didn’t know 
where to go 
(21%) 
 long waiting lists 
(14%) 
 fear of CYF’s 
(14%) 
 no transport 
2008 29% of frequent users 
reported barriers to 
finding help, including: 
 fear of what 
might happen 
once contact 
made with 
service (33%) 
 social pressure to 
keep using (48%) 
 fear of losing 
friends (27%) 
 fear of police 
(20%) 
 didn’t know 
where to go 
(21%) 
 long waiting lists 
(33%) 
 fear of CYF’s 
(20%) 
 concern about 
2011 IDMS  Small numbers of frequent users answered 
these questions (i.e. 31=2008, 22=2009, 
31=2010, 33=2011) so some caution 
should be exercised when interpreting 
comparisons. 
There was a decline in the proportion of 
frequent users who nominated ‘fear of 
police’ and ‘fear of what might happen after 
contacting a service’ as barriers to finding 
help from 2007 to 2011.  
MOH note their contracted 
methamphetamine treatment providers also 
find similar reasons as barriers to help as 
the IDMS survey.  Providers note that many 
users disliked the lengths they had to take 
to finance their habit (e.g. going into debt, 
committing crime, prostitution). 
  
 
Tackling M
etham
phetam
ine: Indicators and P
rogress R
eport O
ctober 2012 
35
P
O
LIC
Y
 A
D
V
IS
O
R
Y
 G
R
O
U
P
Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and notes 
(11%). impact on job/ 
career (23%) 
 costs too much 
(21%) 
 couldn’t get 
appointment at 
good time (20%) 
 no transport 
(14%). 
Access to 
treatment spaces 
by region 
Alcohol and other 
drug (AOD) treatment 
waiting times by 
region as reported by 
community alcohol 
and drug services 
Waiting times between 
referrals to a DHB 
Community Alcohol 
and other Drug Service 
and first appointment:  
 Northern DHBs - 
4.25 weeks 
 Midland DHBs - 
2.6 weeks 
 Central DHBs - 
1.3 weeks 
 Southern DHBs - 
8.75 weeks. 
May 
2009 
 Northern region 
83.2% seen 
within 3 weeks 
 Midland region 
49.5% seen 
within 3 weeks 
 Central region 
56.9% seen 
within 3 weeks 
 Southern region 
64.6% seen 
within 3 weeks. 
Nationally: 66.7% are 
seen within 3 weeks of 
referral. 
January 
- March 
2012 
 
 
DHBs, 
Ministry of 
Health data 
collection,  
ADANZ. 
Lower waiting times. Target times for first contact have been 
reduced from less than 4 weeks to less 
than 3 weeks. 
Data on waiting times 
for residential 
treatment as reported 
by providers.  
Waiting times range 
from 2.5 weeks to 36 
weeks. 
As at 
October 
2009 
The major AOD 
residential providers 
have been contracted 
by the Ministry of 
Health as part of the 
dedicated 
methamphetamine 
treatment pathway. 
68% of clients are 
gaining access to 
dedicated residential 
treatment providers in 
January 
- March 
2012 
 
Information 
direct from 
providers. 
Lower waiting times.  Waiting times are unchanged from last 
reported in April 2011. 
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Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and notes 
less than 4 weeks. 
However, 28% are 
waiting longer than 8 
weeks. 
 
 
Prisoners in 
treatment 
Total prisoners who 
start a substance 
abuse programme in 
a Drug Treatment Unit 
(DTU). 
499 2008/09 907 2011/12 
 
Department 
of 
Corrections  
To ensure that the 
highest numbers of 
prisoners who need 
treatment are 
accessing it, the 
desired direction is an 
increase in the number 
of prisoners in DTUs, 
number of hours 
completed in a DTU 
and percentage of 
prisoners who 
complete a substance 
abuse programme. 
DTU’s in prisons have consistently shown 
significant reductions in rates of re-
imprisonment amongst participants over 
the last seven years.  The most recent 
results indicate that rates of re-
imprisonment amongst programme 
graduates, within one year of release, 
reduced by 20%.  This is based on an 
expected re-imprisonment rate of 32%, 
versus a recorded rate of 25%, or a seven 
percentage-point fall.  
Total hours in 
treatment. 
106,097 172,750 
Completion rates (% 
of those in treatment 
who complete). 
58% 82% (655 out of 802)   
NB Not all DTU 
participants who 
commenced in 
2011/12 completed in 
that year. 
Number of users 
diverted into 
treatment 
Number of Adult 
Police Diversion 
Scheme diversions 
with alcohol and other 
drug assessment, 
treatment or 
counselling as a 
condition of diversion. 
This is broader than 
just 
methamphetamine.  
At least 1,056 
diversions with AOD 
treatment as a 
condition. 
2008 531 
This data may not be 
reliable. The actual 
number of those 
completing AOD 
programmes is likely 
to be higher than the 
number identified. 
Diversion conditions 
may not be 
consistently 
interpreted when data 
is entered into the 
National Intelligence 
Application. This 
inconsistency in data 
1 April – 
31 
August 
2012 
 
 
 
Police Higher percentage of 
users with AOD 
treatment as a 
condition of diversion. 
The "low" number of AOD diversions 
compared to the baseline data is a result of: 
 the increased issuing of formal 
warnings as part of the Alternative 
Resolutions initiative  
 diversions no longer being issued for 
Class A and B offences since March 
2011. 
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Indicator Definition Baseline data Period Latest data  
(at October 2012) 
Period  Source Desired direction Change in indicator and notes 
entry means that 
comparison of data 
from year to year may 
not be accurate. 
Number of offenders 
with 
methamphetamine 
convictions who 
received an Alcohol 
and Drug Assessment 
as a condition of 
sentence. 
 
213 (or 16.8% of total 
methamphetamine 
convictions). 
2008 267 (or 21.3% of total 
methamphetamine 
convictions). 
2011  Ministry of 
Justice 
Higher percentage of 
convictions with AOD 
assessments.  
The number and percentage of total 
methamphetamine convictions with an AOD 
assessment has increased steadily in 
recent years. 
Number of 
methamphetamine 
users occupying 
dedicated beds and 
number assessed 
by the Alcohol Drug 
Helpline  
Measures whether 
beds being utilised 
appropriately for 
methamphetamine 
users. 
36 users accessed 
residential treatment. 
 
17 users accessed 
social detox. 
Jan – 
Mar 
2010 
Between November 
2009 and March 2012, 
over 440 people were 
admitted to residential 
treatment and over 400 
people for social 
detoxification. 
Nov 
2009 to 
March 
2012  
 
Ministry of 
Health via 
dedicated 
contracts – 
from reports 
by providers. 
More users seeking 
treatment. 
The average length of stay in dedicated 
methamphetamine residential treatment 
services has been 66.5 days, with 58% of 
clients achieving planned discharge (i.e., 
completing treatment). 
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Appendix I: Descriptions of information 
sources  
Key sources of information 
Publicly available sources of information are described below.  
New Zealand Arrestee Drug Use Monitoring (NZ-ADUM, formerly NZ-ADAM) 
Description: NZ-ADUM measures drug and alcohol use among people who have been 
recently apprehended and detained in watch houses by Police. 
Owner:   Police  
Researcher: Social and Health Outcomes Research and Evaluation (SHORE), School of 
Public Health, Massey University.  
Frequency: Reported annually. 
Release date:  Varies, generally between July and September. 
Population: Approximately 800 interviewees.  
Key reports:  New Zealand Arrestee Drug Abuse Monitoring Annual Report  
Location: www.police.govt.nz     
 
Illicit Drug Monitoring System (IDMS) 
Description: IDMS is conducted annually to provide a "snapshot" of trends in illegal drug 
use and drug related harm by interviewing frequent drug users. 
Owner:  Police  
Researcher: Social and Health Outcomes Research and Evaluation (SHORE), School of 
Public Health, Massey University. 
Frequency: Annually 
Release date:  Varies, generally between July and September. 
Population: Approximately 400 interviewees.  
Key reports:  Recent Trends in Illegal Drug Use in New Zealand 2006-09. 
Findings from the 2006, 2007, 2008 and 2009 Illicit Drug Monitoring System 
(IDMS). 
Location: www.shore.ac.nz/  www.massey.ac.nz/  
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New Zealand Alcohol and Drug Use Survey/New Zealand Health Survey 
Description: 2007/08 New Zealand Alcohol and Drug Use Survey (NZADUS). 
Owner:   Ministry of Health  
Researcher: Health and Disability Intelligence Unit, Population Surveys, Ministry of 
Health. 
Frequency: NZADUS was a one-off survey. A continuous New Zealand Health Survey 
will include a new, periodic and comprehensive module on alcohol and drug 
use. The first module will be in the field from July 2012 to June 2013. 
Release dates:  Results of the 2007/08 NZADUS were published January 2010. Data from 
the 2012/13 New Zealand Health Survey will be available March 2014. 
Population: New Zealand adult population aged 16–64 years (who were usually 
resident and living in permanent private dwellings). 
Key reports:  Drug Use in New Zealand: Key results of the 2007/08 New Zealand Alcohol 
and Drug Use Survey.  
Location: http://www.health.govt.nz/publication/drug-use-new-zealand-key-results-
2007-08-new-zealand-alcohol-and-drug-use-survey  
 
Other sources of information 
Ministry of Justice conviction statistics  
Description: Sourced from the Ministry of Justice’s Case Management System (CMS). 
Includes all recorded offences, convictions and sentences imposed. 
Owner:   Ministry of Justice 
Researcher: Ministry of Justice 
Frequency: Data collection is on-going 
Release date:  Data is publicly released in June each year, for example 2011 data will be 
released in June 2012. While the Ministry of Justice has access to this data, 
it is not allowed to be used publicly until released.  
Population: Accused and offenders in criminal justice courts 
Key reports:  An Overview of Conviction and Sentencing Statistics in New Zealand 1999 
– 2008. 
Location: www.justice.govt.nz/publications/crime/conviction-and-sentencing   
 
Changes in numbers of Methamphetamine convictions and charges  
In 2009, the Ministry of Justice changed the basis on which court data is reported. Conviction 
data was previously reported against the year in which the case was resolved (whether or 
not a conviction is entered).  However, since 2009, conviction data is based on the last court 
hearing date for the case (i.e. the sentencing date).  For example, the year of a case for a 
person who was convicted on 15 December 2008 and sentenced on 15 January 2009, would 
previously have been attributed to 2008.  Such a case would now be attributed to 2009.  This 
means that the data sets reported since 2009 differ from those used to establish baseline 
data. 
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Figures include convictions that have yet to be (or will not be) appealed, and convictions that 
have been finalised following exhaustion of appeal options for each individual case. They are 
therefore also subject to adjustment each subsequent year as case outcomes are finalised.   
Border seizures of drugs  
Description: Interceptions of drugs and precursors made at the border, almost 
exclusively involving shipments arriving in New Zealand from overseas (as 
opposed to being exported) carried by passengers, concealed in mail or 
concealed in freight. 
Owner:   Customs 
Researcher: Customs and NDIB. 
Frequency: Monthly  
Release dates:  As required. 
Population: N/A 
Key reports:  Monthly Reports from Customs, Monthly NDIB Reports.  
Location: From NDIB and also via Customs Intelligence Planning and Coordination 
Group.  
Drug use attitudes survey 
Description: Research into knowledge and attitudes to illegal drugs. 
Owner:   Ministry of Health 
Researcher: Acqumen Limited/UMR Research Limited. 
Frequency: One-off survey (for Demand Reduction Programme). Note that the 
quantitative component can be repeated relatively simply.  
Release date:  July 2009 
Population: New Zealand adult population; recruitment split between general public and 
people with experience of illegal drug use. 
Key reports:  Research into knowledge and attitudes to illegal drugs: a study among the 
general public and people with experience of illegal drug use. 
Location: National Drug Policy website: www.ndp.govt.nz/ 
 
Alcohol Drug Helpline 
Description: Telephone based assistance for people enquiring about drug and alcohol 
information, advice and support, which includes treatment service 
information. 
Owner:   Ministry of Health/Alcohol Advisory Council (ALAC).  
Researcher: Alcohol Drug Helpline - Addiction Treatment Services Team, Ministry of 
Health. 
Frequency: Quarterly reporting. 
Release date:  Not publicly released – reported to Ministry of Health. 
Population: Those who self-identify with methamphetamine use concerns. 
Key reports:  Contract reporting  
Location: N/A  
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Police Annual Reports 
Description: Outlines strategic context, service performance, financial statements, 
warrants, organisational information and statistical information. In the 
2007/2008 Annual Report the relevant part was “Focusing on illicit drugs 
and alcohol”, under the section “Reducing Inequalities and Managing Risk”.  
Owner:   Police  
Researcher: Police  
Frequency: Annually 
Release date:  October/November 
Population: N/A 
Key reports:  Annual Report 
Location: www.police.govt.nz/resources/index.html#annualreport  
Population prevalence surveys 
Description: New Zealand National Household Drug Survey. 
Owner:   Centre for Social and Health Outcomes Research and Evaluation 
(SHORE).  
Researcher: Massey University 
Frequency: Has been repeated approximately every 2-3 years. 
Release date:  2009 survey, end of 2009. 
Population: New Zealand population aged 15-45 years. 
Key reports:  2009 National Household Survey of Drug Use in New Zealand. 
Location: Available from SHORE, including website: www.shore.ac.nz/ 
DHB/MOH – Access to treatment spaces by region 
Description: General waiting list by time (days) as captured by the Ministry of Health. 
Owner:  Ministry of Health and District Health Boards. 
Researcher: Ministry of Health 
Frequency: Quarterly - end June, end September, end December, end March. 
Release date:  Not publicly released – reported to Ministry of Health. 
Population: Those who have been admitted into formal AOD treatment.  This excludes 
most NGO’s. 
Key reports:  Supplied by services on a quarterly reporting template. 
Location: N/A 
Department of Corrections Prisoners in Treatment 
Description: Number of prisoners receiving treatment including: 
- total prisoners who start a substance abuse programme in a drug 
treatment unit 
- total hours prisoners spend attending substance abuse programmes in a 
drug treatment unit 
- percentage of prisoners who complete a substance abuse programme.  
Owner:  Department of Corrections 
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Researcher: Department of Corrections 
Frequency: Data collection is on-going.  
Release date:  Annual reports released in October each year on the Department of 
Corrections website. 
Population: New Zealand prison population.  
Key reports:  Department of Corrections Annual Report.  
 Department of Corrections progress reports will be reported quarterly from 
late February 2010. 
Location: Annual report available from Corrections website:  
 www.corrections.govt.nz/news-and-publications/statutory-reports/annual-
reports.html    
New social detox and residential beds 
Description: Methamphetamine dedicated beds for “standalone social detox” and 
residential (which includes a social detox component). 
Owner:   Ministry of Health  
Researcher: Addictions Treatment Services Team, Ministry of Health. 
Frequency: Quarterly 
Release date: Not publicly released – reported to Ministry of Health. 
Population: Those admitted to a “standalone social detox” and admitted to a residential 
bed (which includes a social detox). 
Key reports:  Contract reporting.  
Location: N/A 
